HLCS 1.19/1.20 hod 1.39 read the article this is huge
Helicos BioSciences (NASDAQ:HLCS) is up and up sharply on two issues. Late yesterday the company said it had sequenced a human genome. A New York Times article highlighted its ability to decode the human genome for far less cost than what has been the norm.
The article noted that the Heliscope Single Molecule Sequencer will democratize access to the fruits of the genome revolution. The notion is that this will allow a staff of three workers to decode the human genome in as little as four weeks.
Further noted was that only seven human genomes have been successfully decoded. The estimate for the cost of the first one in 2003 was put in the vicinity of $500 million.
Dr. Quake, the creator of the sequencing system, said that the costs of the more recent genome decoding cost roughly $250,000.00 to decode. The projection of the costs using his machine…. about $50,000.
If he is accurate in this, he would be right in the assessment that the floodgates could be opened and many human genomes would be sequenced. Furthermore, it was also noted that the ultimate goal of the $1,000 genome could be attained in two or three years. That could lead to making the decoding process a routine medical procedure.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.